GATC Biotech is the first service provider to offer access to liquid biopsy-based assays with unprecedented flexibility for any stage or any project of blood-based tumour characterisation. Learn more now.
GATC Biotech, a family-owned SME, has participated in a large number of successful publicly funded research projects. Our expertise and the high quality of our work are your guarantee for scientific progress in any kind of collaboration. Strive for genomic innovation and learn more about current publicly funded project.
GATC Biotech, a family- owned business since 1990, is Europe’s leading sequencing services provider with more than 10,000 customers from academia, healthcare and industry worldwide.